Hormone replacement and cardiovascular risk factors

Comment

A Z Bluming. N Engl J Med. 1993.

. 1993 Sep 30;329(14):1042; author reply 1043.

No abstract available

Comment on

Postmenopausal hormone-replacement therapy.
Martin KA, Freeman MW. Martin KA, et al. N Engl J Med. 1993 Apr 15;328(15):1115-7. doi: 10.1056/NEJM199304153281509. N Engl J Med. 1993. PMID: 8455670 No abstract available.

Postmenopausal hormone-replacement therapy.
Martin KA, Freeman MW. Martin KA, et al. N Engl J Med. 1993 Apr 15;328(15):1115-7. doi: 10.1056/NEJM199304153281509. N Engl J Med. 1993. PMID: 8455670 No abstract available.
[Estrogens in menopause--therapy and prevention. III. Estrogen replacement in menopause: uses and risks in prevention and therapy of cardiovascular diseases].
Reincke M, Allolio B. Reincke M, et al. Internist (Berl). 1996 Apr;37(4):410-5; discussion 415. Internist (Berl). 1996. PMID: 8655282 Review. German. No abstract available.
[Comments on the Women's Health Initiative (WHI) and the Million Women Study (MWS) which question the usefulness of hormone substitution during menopause].
Lopes P. Lopes P. J Gynecol Obstet Biol Reprod (Paris). 2003 Oct;32(6):500-2. J Gynecol Obstet Biol Reprod (Paris). 2003. PMID: 14593295 French. No abstract available.
Hormone replacement therapy and the menopause. Australian Menopause Society.
MacLennan AH. MacLennan AH. Med J Aust. 1991 Jul 1;155(1):43-4. Med J Aust. 1991. PMID: 2067437 Review. No abstract available.
Cardiovascular disease, menopause, and the influence of hormone replacement therapy.
Lobo RA. Lobo RA. Prog Clin Biol Res. 1989;320:313-32. Prog Clin Biol Res. 1989. PMID: 2690141 Review. No abstract available.